Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash flows from operating activities:
Net earnings	$ 129,427	$ 104,545
Adjustments to reconcile net earnings to net cash used in operating activities:
Depreciation and amortization	125,821	119,551
Stock-based compensation expense	12,303	10,257
Change in estimated sales allowances	59,865	25,482
Deferred income tax (benefit) expense	(5,250)	7,114
Other non-cash items	54,563	34,582
Litigation settlements, net	2,173	23,966
Changes in operating assets and liabilities:
Accounts receivable	(155,085)	(178,642)
Inventories	(70,095)	(69,727)
Trade accounts payable	(33,077)	28,047
Income taxes	(48,562)	(1,938)
Deferred revenue	(7,043)
Other operating assets and liabilities, net	(174,169)	(148,817)
Net cash used in operating activities	(109,129)	(45,580)
Cash flows from investing activities:
Capital expenditures	(35,745)	(41,339)
Purchase of marketable securities	(2,660)	(2,162)
Proceeds from sale of marketable securities	2,562
Other items, net	(70,318)	126
Net cash used in investing activities	(106,161)	(43,375)
Cash flows from financing activities:
Change in short-term borrowings, net	311,053	(5,561)
Proceeds from issuance of long-term debt	435,000
Payment of long-term debt	(673,806)	(1,205)
Proceeds from exercise of stock options	17,182	23,143
Other items, net	2,498	1,602
Net cash provided by financing activities	91,927	17,979
Effect on cash of changes in exchange rates	6,345	17,011
Net decrease in cash and cash equivalents	(117,018)	(53,965)
Cash and cash equivalents - beginning of period	375,056	662,052
Cash and cash equivalents - end of period	$ 258,038	$ 608,087